©2024 Stanford Medicine
Overcoming Barriers and Obstacles to Adopting Diabetes Devices
Not Recruiting
Trial ID: NCT04161131
Purpose
This study will create a comprehensive, multicomponent behavioral intervention package
(ONBOARD; OvercomiNg Barriers & Obstacles to Adopting Diabetes Devices). ONBOARD will provide
adults with type 1 diabetes (T1D) the skills to maximize benefit and minimize daily
interference from barriers associated with continuous glucose monitoring (CGM) and increase
readiness for closed loop.
Official Title
A Pilot of ONBOARD: OvercomiNg Barriers & Obstacles to Adopting Diabetes Devices for Adults With T1D
Stanford Investigator(s)
Molly Tanenbaum
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism Clinical Assistant Professor (By courtesy), Pediatrics - Endocrinology and Diabetes
Marina Basina
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Eligibility
Inclusion Criteria:
1. Subject is age 18-50 years at time of screening
2. Subject is within first year of continuous glucose monitor use OR has not been using
CGM regularly in the past 6 months
3. Subject has a clinical diagnosis of type 1 diabetes
4. Subject comprehends spoken and written English
Exclusion Criteria:
1. Subject has a medical disorder that in the judgment of the investigator will interfere
with completion of any aspect of the protocol.
2. Subject has a neurologic disorder that in the judgment of the investigator will affect
completion of the protocol.
Intervention(s):
behavioral: ONBOARD
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Molly Tanenbaum, PhD
650-725-3955